Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeuti...
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and one of the most aggressive cancers in man. Despite technological advances in surgical management, combined regimens of radiotherapy with new generation chemotherapy, the median survival for these patients is 14.6 months. This is largely due to a highly deregulated t...
Alternative Titles
Full title
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5d6ccc0622164d39b605caf96922b3b5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d6ccc0622164d39b605caf96922b3b5
Other Identifiers
ISSN
1476-4598
E-ISSN
1476-4598
DOI
10.1186/1476-4598-9-135
